References
1. Ishikawa, E., K. Tsuboi, T. Yamamoto, A. Muroi, T. Enomoto, S.
Takano, A. Matsumura, and T. Ohno. 2007. Clinical trial of autologous
formalin-fixed tumor vaccine for glioblastoma multiforme patients.
Cancer Sci. 98:1226-1233.
2. Sakamoto, N., E. Ishikawa, T. Yamamoto, K. Satomi, K. Nakai, M. Sato,
T. Enomoto, Y. Morishita, S. Takano, T. Ohno, K. Tsuboi, and A.
Matsumura. 2011. Pathological changes after autologous formalin-fixed
tumor vaccine therapy combined with temozolomide for glioblastoma -Three
case reports-. Neurol. Med. Chir (Tokyo). 51:319-325.
3. Muragaki, Y., T. Maruyama, H. Iseki, M. Tanaka, C. Shinohara, K.
Takakura, K. Tsuboi, T. Yamamoto, A. Matsumura, M. Matsutani, K.
Karasawa, K. Shimada, N. Yamaguchi, Y. Nakazato, K. Sato, Y. Uemae, T.
Ohno, Y. Okada, and T. Hori. 2011. Phase I / IIa trial of autologous
formalin-fixed tumor vaccine concomitant with fractionated radiotherapy
for initially-diagnosed glioblastoma. J. Neurosurg. 115:248-255.
4. Ishikawa, E., Y. Muragaki, T. Yamamoto, T. Maruyama, K. Tsuboi, S.
Ikuta, K. Hashimoto, Y. Uemae, T. Ishihara, M. Matsuda, M. Matsutani, K.
Karasawa, Y. Nakazato, T. Abe, T. Ohno, and A. Matsumura. 2014. Phase
I/IIa trial of fractionated radiotherapy, temozolomide, and autologous
formalin-fixed tumor vaccine for newly diagnosed glioblastoma. J.
Neurosurg. 121:543-553.
5. Kuranishi, F., and T. Ohno. 2013. Eradication of breast cancer with
bone metastasis by autologous formalin-fixed tumor vaccine (AFTV)
combined with palliative radiation therapy and adjuvant chemotherapy: a
case report. World J. Surg. Oncol. 11:127.
6. Kuranishi, F., Y. Imaoka, Y. Sumi, Y. Uemae, H. Yasuda-Kurihara, T.
Ishihara, T. Miyazaki, and T. Ohno. 2018. Rate of clinical complete
response for 1 year or more in bone-metastatic breast cancer after
comprehensive treatments including autologous formalin-fixed tumor
vaccine. Int. J. Breast Cancer, article ID 4879406.
7. Miyoshi, T., T. Kashiwabara, A. Asahi, T. Kataoka, T. Maruyama, R.
Okada, Y. Uemae, and T. Ohno. 2017. Complete remission of
chemo-refractory multiple-metastatic upper tract urothelial carcinoma by
autologous formalin-fixed tumor vaccine. Clin. Case Rep. 5:1780-1784.
8. Inui, T., and T. Ohno. 2012. Autologous formalin-fixed tumor vaccine
suppressed re-recurrence of HCV-related hepatocellular carcinoma
following 29 unsuccessful treatments with extensive conventional
therapy: A case report. World J. Surg. Oncol. 10:144.
9. Kawashima, I., Y. Kawashima, Y. Matsuoka, K. Fujise, H. Sakai, M.
Takahashi, T. Yoshikawa, T. Nakatsura, T. Ishihara, and T. Ohno. 2015.
Suppression of postsurgical recurrence of hepatocellular carcinoma
treated with autologous formalin-fixed tumor vaccine, with special
reference to glypican-3. Clin. Case Rep. 3:444-447.
10. Todoroki, T., T. Kondo, S. Sugahara, Y. Morishita, K. Mori, and T.
Ohno. 2011. Long-term survivor of relapsed MFH on the thigh treated with
autologous formalin-fixed tumor vaccine (AFTV) combined with
limb-sparing surgery and radiotherapy. World J. Surg. Oncol. 9:96.
11. Chen, J. T., and T. Ohno. 2015. Recurrent peritoneal serous
carcinoma that was unmanageable with paclitaxel–carboplatin therapy
responded to autologous formalin-fixed tumor vaccine. Clin. Case Rep.